Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes

Biochemical Journal

Volumn 442, Issue 3, 2012, Pages 693-701

  Wu, Yu ^a   Steinbergs, Nora ^a   Murray Stewart, Tracy ^a   Marton, Laurence J ^b   Casero, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epigenetic; Histone; Lysine specific demethylase 1 (LSD1); Ornithine decarboxylase; Polyamine

Indexed keywords

EFLORNITHINE; LYSINE SPECIFIC DEMETHYLASE 1; POLYAMINE DERIVATIVE; SECRETED FRIZZLED RELATED PROTEIN 2; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER GENE THERAPY; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SILENT GENE; TUMOR SUPPRESSOR GENE;

EID: 84863232569     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111271     Document Type: Article

References (47)

1. Baylin, S. B. and Ohm, J. E. (2006) Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116 (Pubitemid 43361543)
2. Marks, P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T. and Kelly, W. K. (2001) Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1, 194-202 (Pubitemid 33741894)
3. Shi, Y. and Whetstine, J. R. (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25, 1-14 (Pubitemid 46049067)
4. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A. and Casero, R. A. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (Pubitemid 40037608)
5. Lee, M. G., Wynder, C., Cooch, N. and Shiekhattar, R. (2005) An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437, 432-435 (Pubitemid 41613507)
6. Huang, Y., Marton, L. J., Woster, P. M. and Casero, R. A. (2009) Polyamine analogues targeting epigenetic gene regulation. Essays Biochem. 46, 95-110
7. Huang, Y., Stewart, T. M., Wu, Y., Baylin, S. B., Marton, L. J., Perkins, B., Jones, R. J., Woster, P. M. and Casero, Jr, R. A. (2009) Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin. Cancer Res. 15, 7217-7228
8. Sharma, S. K., Wu, Y., Steinbergs, N., Crowley, M. L., Hanson, A. S., Casero, R. A. and Woster, P. M. (2010) (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. J. Med. Chem. 53, 5197-5212
9. Zhu, Q., Huang, Y., Marton, L. J., Woster, P. M., Davidson, N. E. and Casero, R. A. (2011) Polyamine analogues modulate gene expression by inhibiting lysine-specific dementhylase 1 (LSD1) and altering chromatin structure in human breast cancer cells. Amino Acids, doi:10.1007/s00726-011-1004-1
10. Huang, Y., Greene, E., Murray-Stewart, T., Goodwin, A., Baylin, S., Woster, P. and Casero, Jr, R. (2007) Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl. Acad. Sci. U.S.A. 104, 8023-8028 (Pubitemid 47185869)
11. Casero, Jr., R. and Marton, L. (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discov. 6, 373-390 (Pubitemid 46705201)
12. Pegg, A. E. (1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J. 234, 249-262
13. Wallace, H. M. (2000) The physiological role of the polyamines. Eur. J. Clin. Invest. 30, 1-3
14. Wallace, H. M. (2003) Polyamines and their role in human disease: an introduction. Biochem. Soc. Trans. 31, 354-355
15. Mamont, P. S., Duchesne, M. C., Grove, J. and Bey, P. (1978) Anti-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem. Biophys. Res. Commun. 81, 58-66 (Pubitemid 8307801)
16. McCann, P. P. and Pegg, A. E. (1992) Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther. 54, 195-215
17. Kabra, P. M., Lee, H. K., Lubich, W. P. and Marton, L. J. (1986) Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. J. Chromatogr. 380, 19-32 (Pubitemid 16049858)
18. Feuerstein, B. G., Williams, L. D., Basu, H. S. and Marton, L. J. (1991) Implications and concepts of polyamine-nucleic acid interactions. J. Cell. Biochem. 46, 37-47
19. Feuerstein, B. G., Pattabiraman, N. and Marton, L. J. (1990) Molecular mechanics of the interactions of spermine with DNA: DNA bending as a result of ligand binding. Nucleic Acids Res. 18, 1271-1282
20. Casero, Jr., R. A. and Woster, P. M. (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44, 1-26 (Pubitemid 32049778)
21. Mitchell, J. L., Thane, T. K., Sequeira, J. M., Marton, L. J. and Thokala, R. (2007) Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs. Amino Acids 33, 291-297 (Pubitemid 47222969)
22. Huang, Y., Hager, E. R., Phillips, D. L., Dunn, V. R., Hacker, A., Frydman, B., Kink, J. A., Valasinas, A. L., Reddy, V. K., Marton, L. J. et al. (2003) A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin. Cancer Res. 9, 2769-2777 (Pubitemid 36842123)
23. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M., Herman, J. and Baylin, S. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31, 141-149
24. Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G. and Shiekhattar, R. (2006) Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 13, 563-567
25. Schmidt, D. M. and McCafferty, D. G. (2007) trans-2- Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry 46, 4408-4416 (Pubitemid 46559406)
26. Yang, M., Culhane, J. C., Szewczuk, L. M., Jalili, P., Ball, H. L., Machius, M., Cole, P. A. and Yu, H. (2007) Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2- phenylcyclopropylamine. Biochemistry 46, 8058-8065 (Pubitemid 47051641)
27. Lawrence, R. J., Earley, K., Pontes, O., Silva, M., Chen, Z. J., Neves, N., Viegas, W. and Pikaard, C. S. (2004) A concerted DNA methylation/histone methylation switch regulates rRNA gene dosage control and nucleolar dominance. Mol. Cell 13, 599-609 (Pubitemid 38299386)
28. Pegg, A. E., Poso, H., Shuttleworth, K. and Bennett, R. A. (1982) Effect of inhibition of polyamine synthesis on the content of decarboxylated S-adenosylmethionine. Biochem. J. 202, 519-526
29. Frostesjo, L., Holm, I., Grahn, B., Page, A. W., Bestor, T. H. and Heby, O. (1997) Interference with DNA methyltransferase activity and genome methylation during F9 teratocarcinoma stem cell differentiation induced by polyamine depletion. J. Biol. Chem. 272, 4359-4366 (Pubitemid 27078511)
30. Jenuwein, T. and Allis, C. D. (2001) Translating the histone code. Science 293, 1074-1080 (Pubitemid 32758077)
31. Jones, P. A. and Baylin, S. B. (2007) The epigenomics of cancer. Cell 128, 683-692 (Pubitemid 46273572)
32. Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A. et al. (2009) Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 10, 223-232
33. Gore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E. et al. (2006) Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res. 66, 6361-6369
34. 1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. Cancer Chemother. Pharmacol. 56, 83-90
35. Wang, Y., Murray-Stewart, T., Devereux, W., Hacker, A., Frydman, B., Woster, P. M. and Casero, Jr, R.A. (2003) Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem. Biophys. Res. Commun. 304, 605-611 (Pubitemid 36513529)
36. Carruthers, L. M., Marton, L. J. and Peterson, C. L. (2007) Polyamine analogues: potent inducers of nucleosomal array oligomerization and inhibitors of yeast cell growth. Biochem. J. 405, 541-545 (Pubitemid 47172052)
37. Metzger, E., Wissmann, M., Yin, N., Muller, J. M., Schneider, R., Peters, A. H., Gunther, T., Buettner, R. and Schule, R. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436-439 (Pubitemid 41613508)
38. Wissmann, M., Yin, N., Muller, J. M., Greschik, H., Fodor, B. D., Jenuwein, T., Vogler, C., Schneider, R., Gunther, T., Buettner, R. et al. (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 9, 347-353
39. Garcia-Bassets, I., Kwon, Y. S., Telese, F., Prefontaine, G. G., Hutt, K. R., Cheng, C. S., Ju, B. G., Ohgi, K. A., Wang, J., Escoubet-Lozach, L. et al. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128, 505-518 (Pubitemid 46198894)
40. Lim, S., Janzer, A., Becker, A., Zimmer, A., Schule, R., Buettner, R. and Kirfel, J. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31, 512-520
41. Perillo, B., Ombra, M. N., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., Chiariotti, L., Malorni, A., Abbondanza, C. and Avvedimento, E. V. (2008) DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319, 202-206
42. Yamamoto, D., Shima, K., Matsuo, K., Nishioka, T., Chen, C. Y., Hu, G. F., Sasaki, A. and Tsuji, T. (2010) Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line. PLoS ONE 5, e12554
43. Meyskens, Jr, F.L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E., Kelloff, G., Lawson, M. J., Kidao, J., McCracken, J. et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev. Res. 1, 32-38
44. Hobbs, C. A., Paul, B. A. and Gilmour, S. K. (2002) Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors. Cancer Res. 62, 67-74 (Pubitemid 34073988)
45. Hobbs, C. A., Paul, B. A. and Gilmour, S. K. (2003) Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation. Exp. Cell Res. 290, 427-436 (Pubitemid 37272185)
46. Wei, G., Hobbs, C. A., Defeo, K., Hayes, C. S. and Gilmour, S. K. (2007) Polyamine-mediated regulation of protein acetylation in murine skin and tumors. Mol. Carcinog. 46, 611-617 (Pubitemid 47255176)
47. Muscari, C., Bonafe, F., Carboni, M., Govoni, M., Stanic, I., Gamberini, C., Ricci, F., Tazzari, P. L., Caldarera, C. M. and Guarnieri, C. (2008) Difluoromethyl-ornithine stimulates early cardiac commitment of mesenchymal stem cells in a model of mixed culture with cardiomyocytes. J. Cell. Biochem. 103, 1046-1052 (Pubitemid 351342598)